Pathogenic roles of B cells in human autoimmunity; insights from the clinic (Q35772863)

10 August 2017

1 reference

title

Pathogenic roles of B cells in human autoimmunity; insights from the clinic (English)

1 reference

10 August 2017

Flavius Martin

1

1 reference

10 August 2017

Andrew C Chan

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

20

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

517-527

1 reference

Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Chemokines in lymphopoiesis and lymphoid organ development

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The role of long-lived plasma cells in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Generation of memory B cells and plasma cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Pathophysiology of immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Maintenance of serological memory by polyclonal activation of human memory B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

1 reference

7 January 2021

Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Cutting edge: B cells promote CD8+ T cell activation in MRL-Fas(lpr) mice independently of MHC class I antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Delineation of the Thymic and Bursal Lymphoid Systems in the Chicken

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Effects of anti-Ig antibodies on the development and differentiation of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Chemokines and cell migration in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

1 reference

7 January 2021

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Mechanisms of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Independent signals regulate development of primary and secondary follicle structure in spleen and mesenteric lymph node

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Organogenic role of B lymphocytes in mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Clinical research helps elucidate the role of tumor necrosis factor-αin the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The diabetes-prone NZO/HlLt strain. I. Immunophenotypic comparison to the related NZB/BlNJ and NZW/LacJ strains.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Long-lived plasma cells in immunity and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The complement system as a therapeutic target in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Tolerance and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Abandoned therapies and unpublished trials in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

CpG motifs: the active ingredient in bacterial extracts?

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

An open study of B lymphocyte depletion in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Lifetime of plasma cells in the bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Anti-idiotype vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Antiplatelet antibodies in chronic adult immune thrombocytopenic purpura: assays and epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Autoantibodies to alpha(IIb)beta(3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha(IIb).

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Splenic T zone development is B cell dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Susceptibility genes in the pathogenesis of murine lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Treatment of IgM antibody associated polyneuropathies using rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Anti-DNA and autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Tumor necrosis factor blockers in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

1 reference

7 January 2021

Ribosomal P antibodies and CNS lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Treatment of autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Monoclonal antibodies in the treatment of autoimmune cytopenias

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Hughes syndrome crosses boundaries

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Upcoming biologic agents for the treatment of rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

The role of B cells in lpr/lpr-induced autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

B-cell origin of cold agglutinins.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

T cell activation in rheumatoid synovium is B cell dependent

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Antigen dependent and independent mechanisms that sustain serum antibody levels

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Cryoglobulins in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Activation of autoreactive B cells by CpG dsDNA

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Unravelling the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Differential in vivo effects of rituximab on two B-cell subsets in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Complement. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Complement. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Autoimmunity in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Ectopic Germinal Center Formation in Rheumatoid Synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Rituximab in the treatment of acquired factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Evolution of autoantibody responses via somatic hypermutation outside of germinal centers

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2804%2900112-8

7 January 2021

10.1016/S1074-7613(04)00112-8

Identifiers

DOI

1 reference

10 August 2017

1 reference